02.09.2013
- Generic drug maker Teva Pharmaceutical Industries said it will stop the development of a depression treatment after a late-stage trial failed to show the drug was more effective...
04.05.2011
- Teva Pharmaceutical Industries struck a deal to acquire U.S. specialty drugmaker Cephalon for nearly $7 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals...
21.12.2010
- Frank Baldino Jr., chief executive and founder of biotechnology company Cephalon, died Thursday night at the age of 57, the company said. The cause of death was not disclosed...
